Positron Corporation (POSC)

[bpatient]

Investing in this company has always revolved around its product pipeline (primarily isotopes). Regardless of Positron's slow and painful execution of its plan, their product lineup (if all comes to fruition) will be impressive within a growing PET market. They reported sales of radiopharmaceuticals in Q3 2014 (although it was only $5000 in value), and hopefully this is just the beginning.
Once Positron begins consistently reporting isotope revenues and cyclotron financing is secured, its market cap will be in the billions. If the market can value any joker with matching socks that comes up with a new "APP" at 20+ billion USD, I'm positive that Positron will be worth at least a few billion.